Position in CGEN
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$14,046
New position
Shares Held
6,564
first reported quarter
Ownership
0.007%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#66
of 82 holders
Holding Since
Jun 2026
1 quarter on record
Position in Biotechnology
Healthcare · as of Jun 30, 2026Spire Wealth Management holds $7,680,555 across 34 Biotechnology names. CGEN ranks #19 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
16,140 | $3,022,698 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,953 | $970,113 | |
| 3 | ARGX |
Argenx SE
|
914 | $847,981 | |
| 4 | NTLA |
Intellia Therapeutics, Inc.
|
39,516 | $668,610 | |
| 5 | HALO |
Halozyme Therapeutics, Inc.
|
7,144 | $559,160 | |
| 6 | EXEL |
Exelixis, Inc.
|
8,794 | $478,481 | |
| 7 | SRRK |
Scholar Rock Holding Corp
|
6,303 | $346,665 | |
| 8 | PVLA |
Palvella Therapeutics, Inc.
|
1,000 | $152,820 |
All Filings in CGEN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,046 | 6,564 | Shares | Sole | 2026-07-15 | |
| No filing history on record for this holder in this stock. | ||||||